Long-term safety and efficacy of indacaterol, a long-acting β2-agonist, in subjects with COPD: A randomized, placebo-controlled study

Kenneth R. Chapman, Stephen I. Rennard, Angeli Dogra, Roger Owen, Cheryl Lassen, Benjamin Kramer

Research output: Contribution to journalArticle

115 Scopus citations

Fingerprint Dive into the research topics of 'Long-term safety and efficacy of indacaterol, a long-acting β<sub>2</sub>-agonist, in subjects with COPD: A randomized, placebo-controlled study'. Together they form a unique fingerprint.

Medicine & Life Sciences